참고문헌
- Jae-Gab P. Cancer Incidence of Korea 1999-2001. Seoul, Republic of Korea; Ministry of Health and Welfare, 2005:157
- Perez CA, Grigsby PW, Nene SM, et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 1992;69:2796-2806 https://doi.org/10.1002/1097-0142(19920601)69:11<2796::AID-CNCR2820691127>3.0.CO;2-O
- Fletcher GH. Cancer of the uterine cervix. janeway lecture, 1970. Am J Roentgenol Radium Ther Nucl Med 1971;111:225-242
- Kim RY, Trotti A, Wu CJ, Soong SJ, Salter MM. Radiation alone in the treatment of cancer of the uterine cervix: analysis of pelvic failure and dose response relationship. Int J Radiat Oncol Biol Phys 1989;17:973-978 https://doi.org/10.1016/0360-3016(89)90144-2
- Kil WJ, Chun MS, Kang SH, et al. Rdiotherapy results in stage IIB uterine cervix cancer. J Korean Soc Ther Radiol Oncol 2001;19:345-352
- Kuske RR, Perez CA, Jacobs AJ, et al. Mini-colpostats in the treatment of carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1988;14:899-906 https://doi.org/10.1016/0360-3016(88)90012-0
- Montana GS, Fowler WC, Varia MA, Walton LA, Mack Y, Shemanski L. Carcinoma of the cervix, stage III. results of radiation therapy. Cancer 1986;57:148-154 https://doi.org/10.1002/1097-0142(19860101)57:1<148::AID-CNCR2820570130>3.0.CO;2-7
- Clark BG, Souhami L, Roman TN, Evans MD, Pla C. Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate brachytherapy: a dosimetric analysis. Int J Radiat Oncol Biol Phys 1994;28:1243-1250 https://doi.org/10.1016/0360-3016(94)90501-0
- Stryker JA, Bartholomew M, Velkley DE, et al. Bladder and rectal complications following radiotherapy for cervix cancer. Gynecol Oncol 1988;29:1-11 https://doi.org/10.1016/0090-8258(88)90140-0
- Withers HR. Biologic basis for altered fractionation schemes. Cancer 1985;55:2086-2095 https://doi.org/10.1002/1097-0142(19850501)55:9+<2086::AID-CNCR2820551409>3.0.CO;2-1
- Withers HR, Thames HD Jr, Peters LJ. A new isoeffect curve for change in dose per fraction. Radiother Oncol 1983;1:187-191 https://doi.org/10.1016/S0167-8140(83)80021-8
- Williams MV, Denekamp J. Radiation induced renal damage in mice: Influence of fraction size. Int J Radiat Oncol Biol Phys 1984;10:885-893 https://doi.org/10.1016/0360-3016(84)90391-2
- Ang KK, Howard D. Altered fractionation schedules. In: Perez CA, Brady LW, eds. Principles and Practice of Radiation Oncology. 4th ed. Philadelphia, PA: Lippincott Co. 2004:337-356
- Saunders MI, Dische S. Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchus. Int J Radiat Oncol Biol Phys 1990;19:1211-1215 https://doi.org/10.1016/0360-3016(90)90231-8
- Saunders M, Dische S, Barrett A, Harvey A, Gibson D, Parmar M. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART steering committee. Lancet 1997;350:161-165 https://doi.org/10.1016/S0140-6736(97)06305-8
- Suit HD. The american society of therapeutic radiologists presidential address: October 1981. potential for improving survival rates for the cancer patient by increasing the efficacy of treatment of the primary lesion. Cancer 1982;50:1227-1234 https://doi.org/10.1002/1097-0142(19821001)50:7<1227::AID-CNCR2820500702>3.0.CO;2-J
- Fletcher GH. Squamous cell carcinoma of the uterine cervix: treatment technique according to size of the cervical lesion and extension. 1980
- Leibel S, Bauer M, Wasserman T, et al. Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: preliminary report of a radiation therapy oncology group randomized trial. Int J Radiat Oncol Biol Phys 1987;13:541-549 https://doi.org/10.1016/0360-3016(87)90069-1
- Piver MS, Barlow JJ, Vongtama V, Blumenson L. Hydroxyurea: a radiation potentiator in carcinoma of the uterine cervix. A randomized double-blind study. Am J Obstet Gynecol 1983;147:803-808 https://doi.org/10.1016/0002-9378(83)90043-1
- John M, Flam M, Sikic B, et al. Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: a phase I-II prospective intergroup NCOG-RTOG study. Gynecol Oncol 1990;37:1-5 https://doi.org/10.1016/0090-8258(90)90296-W
- Marcial VA, Amato DA, Marks RD, et al. Split-course versus continuous pelvis irradiation in carcinoma of the uterine cervix: A prospective randomized clinical trial of the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 1983;9:431-436 https://doi.org/10.1016/0360-3016(83)90058-5
- Maor MH, Gillespie BW, Peters LJ, et al. Neutron therapy in cervical cancer: results of a phase III RTOG study. Int J Radiat Oncol Biol Phys 1988;14:885-891 https://doi.org/10.1016/0360-3016(88)90010-7
- Johnson RJ, Walton RJ. Sequential study on the effect of the addition of hyperbaric oxygen on the 5 year survival rates of carcinoma of the cervix treated with conventional fractional irradiations. Am J Roentgenol Radium Ther Nucl Med 1974;120:111-117 https://doi.org/10.2214/ajr.120.1.111
- Ward AJ, Dixon B. Carcinoma of the cervix: results of a hyperbaric oxygen trial associated with the use of the cathetron. Clin Radiol 1979;30:383-387 https://doi.org/10.1016/S0009-9260(79)80213-5
- Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-146 https://doi.org/10.3109/02841868809090333
- Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992;25:273-279
- Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the uterine cervix. I. impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995;32:1275-1288 https://doi.org/10.1016/0360-3016(95)00220-S
- Komaki R, Pajak TF, Marcial VA, et al. Twice-daily fractionation of external irradiation with brachytherapy in bulky carcinoma of the cervix. phase I/II study of the radiation therapy oncology group 88-05. Cancer 1994;73:2619-2625 https://doi.org/10.1002/1097-0142(19940515)73:10<2619::AID-CNCR2820731025>3.0.CO;2-P
- MacLeod C, Bernshaw D, Leung S, Narayan K, Firth I. Accelerated hyperfractionated radiotherapy for locally advanced cervix cancer. Int J Radiat Oncol Biol Phys 1999;44:519-524 https://doi.org/10.1016/S0360-3016(99)00043-7
- Perez CA, Grigsby PW, Chao KS, Mutch DG, Lockett MA. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 1998;41:307-317 https://doi.org/10.1016/S0360-3016(98)00067-4
- Denekamp J. Changes in the rate of repopulation during multifraction irradiation of mouse skin. Br J Radiol 1973;46:381-387 https://doi.org/10.1259/0007-1285-46-545-381
- Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992;23:457-467 https://doi.org/10.1016/0360-3016(92)90768-D
- Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a gynecologic oncology group and southwest oncology group study. J Clin Oncol 1999;17:1339-1348 https://doi.org/10.1200/JCO.1999.17.5.1339
- Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-1143 https://doi.org/10.1056/NEJM199904153401501
- Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-1153 https://doi.org/10.1056/NEJM199904153401502
- Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-1613 https://doi.org/10.1200/JCO.2000.18.8.1606
- Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-1161 https://doi.org/10.1056/NEJM199904153401503
- Chun M, Kang S, Ryu H, et al. Modified partial hyperfractionation in radiotherapy for bulky uterine cervical cancer: Reduction of overall treatment time. Int J Radiat Oncol Biol Phys 2000;47:973-977 https://doi.org/10.1016/S0360-3016(00)00539-3
- Lanciano R, Calkins A, Bundy BN, et al. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study. J Clin Oncol 2005;23:8289-8295 https://doi.org/10.1200/JCO.2004.00.0497
- Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004;22:872-880 https://doi.org/10.1200/JCO.2004.07.197
- Saibishkumar EP, Patel FD, Sharma SC. Results of a phase II trial of concurrent chemoradiation in the treatment of locally advanced carcinoma of uterine cervix: an experience from india. Bull Cancer 2005;92:E7-12 https://doi.org/10.1038/sj.bjc.6602229
- Nakano T, Kato S, Ohno T, et al. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix. Cancer 2005;103:92-101 https://doi.org/10.1002/cncr.20734